Status:
COMPLETED
Protective Antibody Level After COVID-19 Vaccination Among Patients Under Hemodialysis
Lead Sponsor:
Hanyang University Seoul Hospital
Collaborating Sponsors:
Seegene Medical Foundation
Conditions:
Covid19
Vaccine Reaction
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the study is to evaluate the level of neutralizing antibody against SARS-CoV-2 after COVID-19 vaccination in patients under hemodialysis. To this end, the level of neutralizing antibody of ...
Eligibility Criteria
Inclusion
- The person who is vaccinated with ChAdOx1 (COVID-19 vaccine)
- The person who agrees with the protocol of the study
Exclusion
- Age \< 18 years
- Pregnants
- Experience of COVID-19 infection
Key Trial Info
Start Date :
April 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2021
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT04871945
Start Date
April 20 2021
End Date
October 31 2021
Last Update
March 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hanyang University Seoul Hospital
Seoul, South Korea